Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark.
Hemodial Int. 2024 Jan;28(1):40-50. doi: 10.1111/hdi.13118. Epub 2023 Oct 12.
Fluid overload is a major challenge in hemodialysis patients and might cause hypervolemia. We speculated that hemodialysis patients reaching dry weight could have undetected hypervolemia and low hemoglobin (Hb) concentration (g/dL) due to hemodilution.
The study included hemodialysis patients (n = 22) and matched healthy controls (n = 22). Blood volume, plasma volume, red blood cell volume, and total Hb mass were determined using a carbon monoxide (CO)-rebreathing method in hemodialysis patients reaching dry weight and controls. Blood volume measurements were also obtained by a dual-isotope labeling technique in a subgroup for validation purposes.
In the hemodialysis group, the median specific blood volume was 89.3 mL/kg (interquartile range [IQR]: 76.7-95.4 mL/kg) and was higher than in the control group (79.9 mL/kg [IQR: 70.4-88.0 mL/kg]; p < 0.037). The median specific plasma volume was 54.7 mL/kg (IQR: 47.1-61.0 mL/kg) and 44.0 mL/kg (IQR: 38.7-49.5 mL/kg) in the hemodialysis and control groups, respectively (p < 0.001). Hb concentration was lower in hemodialysis patients (p < 0.001), whereas no difference in total Hb mass was observed between groups (p = 0.11). A correlation was found between blood volume measured by the CO-rebreathing test and the dual-isotope labeling technique in the control group (r = 0.83, p = 0.015), but not the hemodialysis group (r = 0.25, p = 0.60).
The hemodialysis group had increased specific blood volume at dry weight due to high plasma volume, suggesting a hypervolemic state. However, correlation was not established against the dual-isotope labeling technique underlining that the precision of the CO-rebreathing test should be further validated. The total Hb mass was similar between hemodialysis patients and controls, unlike Hb concentration, which emphasizes that Hb concentration is an inaccurate marker of anemia among hemodialysis patients.
液体超负荷是血液透析患者的主要挑战,可能导致血容量过多。我们推测,达到干体重的血液透析患者可能由于血液稀释而存在未被发现的血容量过多和低血红蛋白(Hb)浓度(g/dL)。
该研究纳入了 22 名血液透析患者(n=22)和 22 名匹配的健康对照者(n=22)。通过一氧化碳(CO)再呼吸法测定达到干体重的血液透析患者和对照组者的血容量、血浆容量、红细胞容量和总 Hb 质量。通过双同位素标记技术在亚组中获得血容量测量值,以验证目的。
在血液透析组中,中位特异性血容量为 89.3 mL/kg(四分位距 [IQR]:76.7-95.4 mL/kg),高于对照组(79.9 mL/kg [IQR:70.4-88.0 mL/kg];p<0.037)。血液透析组和对照组的中位特异性血浆容量分别为 54.7 mL/kg(IQR:47.1-61.0 mL/kg)和 44.0 mL/kg(IQR:38.7-49.5 mL/kg)(p<0.001)。血液透析患者的 Hb 浓度较低(p<0.001),但两组之间总 Hb 质量无差异(p=0.11)。在对照组中,CO 再呼吸试验测量的血容量与双同位素标记技术之间存在相关性(r=0.83,p=0.015),但在血液透析组中没有相关性(r=0.25,p=0.60)。
在达到干体重时,血液透析组的特异性血容量增加,这是由于高血浆量引起的,表明存在血容量过多的状态。然而,与双同位素标记技术相比,没有建立相关性,这突出表明 CO 再呼吸试验的精度需要进一步验证。血液透析患者和对照组之间的总 Hb 质量相似,与 Hb 浓度不同,这强调了 Hb 浓度是血液透析患者贫血的一个不准确的标志物。